✦ LIBER ✦

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation: A Real-World Setting

✍ Scribed by Fontaine, Gabriel V. (author);Mathews, Katy D. (author);Woller, Scott C. (author);Stevens, Scott M. (author);Lloyd, James F. (author);Evans, R. Scott (author)

Book ID: 125529545
Publisher: SAGE Publications Inc.
Year: 2014
Tongue: English
Weight: 233 KB
Volume: 20
Category: Article
ISSN: 1076-0296
DOI: 10.1177/1076029614536606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Major Bleeding With Dabigatran and Rivar

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation: A Real-World Setting

✍ Fontaine, Gabriel V. (author);Mathews, Katy D. (author);Woller, Scott C. (author 📂 Article 📅 2014 🏛 SAGE Publications Inc. 🌐 English ⚖ 233 KB

Myocardial Ischemic Events in ‘Real Worl

Myocardial Ischemic Events in ‘Real World’ Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin

✍ Larsen, Torben Bjerregaard; Rasmussen, Lars Hvilsted; Gorst-Rasmussen, Anders; S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 1001 KB

Coagulation assays and plasma fibrinogen

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

✍ Chin, Paul K. L.; Patterson, David M.; Zhang, Mei; Jensen, Berit P.; Wright, Dan 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Efficacy and Safety of Dabigatran Etexil

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

✍ Larsen, Torben Bjerregaard; Rasmussen, Lars Hvilsted; Skjøth, Flemming; Due, Kar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 577 KB

REAL WORLD DISCONTINUATION RATES WITH AP

REAL WORLD DISCONTINUATION RATES WITH APIXABAN VERSUS WARFARIN, DABIGATRAN, OR RIVAROXABAN AMONG ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON ANTICOAGULATION THERAPY: EARLY FINDINGS

✍ Pan, Xianying; Kachroo, Sumesh; Liu, Xianchen; Kawabata, Hugh; Phatak, Hemant 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 638 KB

COMBINATION OF ASA WITH DABIGATRAN OR RI

COMBINATION OF ASA WITH DABIGATRAN OR RIVAROXABAN INCREASES RISK OF BLEEDING WITHOUT ADDITIONAL BENEFIT OF STROKE REDUCTION IN PATIENTS WITH ATRIAL FIBRILLATION

✍ Strunets, Anton; Mirza, Mahek; Cho, Chi; Sra, Jasbir; Jahangir, Arshad 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 966 KB